The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|February 1, 2020
- Pharmaceutical Technology-02-01-2020
- Volume 2020 Supplement
- Issue 1
Pharmaceutical Technology North America, Partnering for Bio/Pharma Success 2020 Supplement (PDF)
Click the title above to open the Pharmaceutical Technology Partnering for Bio/Pharma Success 2020 in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Building a Business Case for Quality Management Transformationalmost 7 years ago
Building Strategic Relationships with CROsalmost 7 years ago
Pharma Contract Market Updatealmost 7 years ago
Digitalization: A CDMO’s Perspectivealmost 7 years ago
Sourcing Success in Cell and Gene Therapy Developmentalmost 7 years ago
More Capacity and Technology Translate to More Optionsalmost 7 years ago
Growth in Biologics Market Inspires OutsourcingAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI Formulation: Regulators Want Data
2
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
3
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
4
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
5